Declining 1-year case-fatality of stroke and increasing coverage of vascular risk management: Populationbased cohort study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 4, 2010, Pages 416-422

  Gulliford, Martin C ^a   Charlton, Judith ^a   Rudd, Anthony ^a   Wolfe, Charles D ^a   Toschke, André Michael ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC NEURON BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AGED; ARTICLE; CLINICAL RESEARCH; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; FATALITY; FEMALE; GENERAL PRACTICE; GROUPS BY AGE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POISSON DISTRIBUTION; POPULATION; PRESCRIPTION; PRIORITY JOURNAL; RISK MANAGEMENT; SEX; STROKE; UNITED KINGDOM;

EID: 77950601817     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.193136     Document Type: Article

References (36)

1. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. The Lancet Neurology 2009;8:345-54.
2. Goldacre MJ, Duncan M, Griffith M, et al. Mortality rates for stroke in England from 1979 to 2004: trends, diagnostic precision, and artifacts. Stroke 2008;39:2197-203.
3. Carter KN, Anderson CS, Hackett ML, et al. Improved survival after stroke: is admission to hospital the major explanation? Trend analyses of the Auckland Regional Community Stroke Studies. Cerebrovasc Dis 2007;23:162-8.
4. Feigin VL, Lawes CM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53.
5. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). The Lancet 2004;363:1925-33.
6. Sarti C, Tuomilehto J, Sivenius J, et al. Declining trends in incidence, case-fatality and mortality of stroke in three geographic areas of Finland during 1983-1989. Results from the FINMONICA stroke register. J Clin Epidemiol 1994;47:1259-69.
7. Stegmayr B, Asplund K. Exploring the declining case fatality in acute stroke. Population-based observations in the northern Sweden MONICA Project. J Intern Med 1996;240:143-9.
8. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007;(4):CD000197.
9. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338: b1665.
10. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. The Lancet Neurology 2009;8:453-63.
11. Sandercock PA, Counsell C, Gubitz GJ, et al. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2008;(3):CD000029.
12. Coleman K, Austin BT, Brach C, et al. Evidence on the Chronic Care model in the new millennium. Health Aff 2009;28:75-85.
13. Shojania KG, Grimshaw JM. Evidence-based quality improvement: the state of the science. Health Aff 2005;24:138-50.
14. Charlton J, Latinovic R, Gulliford MC. Explaining the decline in early mortality in men and women with type 2 diabetes. Population-based cohort study. Diabetes Care 2008;31:1761-6.
15. Irwin P, Hoffman A, Lowe D, et al. Improving clinical practice in stroke through audit: results of three rounds of National Stroke Audit. J Eval Clin Pract 2005;11:306-14.
16. Raine R, Wong W, Ambler G, et al. Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study. BMJ 2009;338:b1279.
17. National statistics. Key health statistics from general practice 1998. Series MB6 No 2. London: National Statistics, 2000.
18. Lawson DH, Sherman V, Hollowell J. The General Practice Research Database. Scientific and Ethical Advisory Group. QJM 1998;91:445-52.
19. Lawrenson R, Todd JC, Leydon GM, et al. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000;49:591-6.
20. Jick H. Vaidation of information recorded on general practitioner based compuertised data resource in the United Kingdom. BMJ 1991;302:766-8.
21. Hansell A, Hollowell J, Nichols T, et al. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999;54:413-19.
22. Gulliford MC, Charlton J, Ashworth M, et al. Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database. PLoS One 2009;4:e7168.
23. Doran T, Fullwood C, Gravelle H, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006;355:375-84.
24. Stata Coroporation. Stata statistical software: release 10. College Station, Texas: Stata Press, 2008.
25. Doran T, Fullwood C, Kontopantelis E, et al. Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework. Lancet 2008;372:728-36
26. Intercollegiate Stroke Working Party. National clinical guidelines for stroke. 3rd edn. London: Royal College of Physicians, 2008.
27. Bejot Y, Rouaud O, Durier J, et al. Decrease in the stroke case fatality rates in a French population-based twenty-year study. A comparison between men and women. Cerebrovasc Dis 2007;24:439-44.
28. Morikawa Y, Nakagawa H, Naruse Y, et al. Trends in stroke incidence and acute case fatality in a Japanese rural area: the Oyabe study. Stroke 2000;31:1583-7.
29. Kleindorfer D, Broderick J, Khoury J, et al. The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke 2006;37:2473-8.
30. Saposnik G, Hill MD, O'Donnell M, et al. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke 2008;39:2318-24.
31. Gulliford MC, Charlton J, Latinovic R. Trends in anti-hypertensive and lipid lowering therapy in type 2 diabetes: clinical effectiveness or clinical discretion? J Human Hypertension 2005;19:111-17.
32. Toschke AM, Wolfe CD, Heuschmann PU, et al. Antihypertensive treatment after stroke and all-cause mortalitydan Analysis of the General Practitioner Research Database (GPRD). Cerebrovasc Dis 2009;28:105-11.
33. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741-8.
34. Numminen H, Kaste M, Aho K, et al. Decreased severity of brain infarct can in part explain the decreasing case fatality rate of stroke. Stroke 2000;31:651-5.
35. Lawlor DA, Smith GD, Leon DA, et al. Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis. The Lancet 2002;360:1818-23.
36. Tudor HJ. Commentary: three decades of the inverse care law. BMJ 2000;320:18-19.